BING is an antimicrobial peptide that can be isolated from Japanese medaka fish. BING shows a broad-spectrum toxicity against pathogenic bacteria including drug-resistant strains. BING induces a deregulation of periplasmic peptidyl-prolyl isomerases in gram-negative bacteria, and reduces the RNA level of cpxR , which plays a crucial role in the development of antimicrobial resistance.
사양
보관 조건
Store at -20°C
배송
Ice chest + Ice pads
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
작업 유형
INHIBITOR
이름과 식별자
분자량
1464.84
고급 데이터
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
솔루션 계산기
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
리뷰
고객 리뷰
Application Protocols
No validated, item-specific application protocols are provided.
General starting points for small-molecule screening (research use only):
Stock solution: Prepare at 10–50 mM in DMSO (if soluble). Aliquot to avoid repeated freeze–thaw. Record exact concentration by weight-in or quantitative NMR if critical.
Assay dilution: Titrate to desired top concentration while maintaining constant DMSO across wells/conditions. Include vehicle controls and, if possible, positive/negative references.
Data quality: Use replicate wells, Z’-factor assessment for HTS robustness, and curve-fitting with appropriate models (four-parameter logistic).
Note: These are general guidelines and not specifications for this item. Follow your institution’s SOPs and adapt conditions to the specific assay and to the compound’s confirmed properties.
Biological Roles
No biological role, target, or mechanism is provided for this item. As a library small molecule, any biological activity, if present, must be established empirically and confirmed with orthogonal assays.
General considerations for research compounds:
Potential activities are unknown a priori; initial screens may reveal interactions with enzymes, receptors, transporters, or protein–protein interfaces.
Follow-up profiling should include counterscreens against common assay interferences (e.g., redox cycling in HRP-coupled assays, detergent-sensitive aggregation, fluorescence quenching/inner-filter effects).
Establish concentration–response relationships (e.g., IC50/EC50) with proper controls and replicate experiments.
Evaluate selectivity across related targets or panels to characterize off-target liabilities.
Biochemical context (general):
Physicochemical properties (pKa, logD, HBD/HBA, TPSA) strongly influence permeability, solubility, and non-specific binding. Determine these experimentally or computationally once the structure is available.
For cellular work, assess cytotoxicity windows (e.g., CellTiter-Glo/Resazurin) and rule out nonspecific membrane disruption.
Important: No medical or clinical claims are made. This product is for research use only.
Buffer Applications
Buffer formulation guidance is generally not applicable without knowing the compound’s ionization behavior and stability. This item does not include buffer system recommendations.
General advice (if preparing assay dilutions):
Start from DMSO stock and dilute into assay buffer while keeping final DMSO at or below the assay’s tolerance (often ≤0.5–1% v/v).
If the compound is ionizable (once known), choose a buffer within ±1 pH unit of its pKa for solubility control, provided the compound is stable at that pH.
Common assay buffers (HEPES pH 7.4, phosphate pH 7.2, Tris pH 7.5) may be used if demonstrated compatible; add 0.01–0.05% nonionic surfactant to mitigate aggregation if assay allows.
Item-specific buffer parameters (pH range, ionic strength, additives): Not specified for this item; refer to CoA/Spec Sheet once available.
Green Alternatives
Item-specific solvent or process data are unavailable; the following green chemistry considerations apply generally when handling small-molecule screening compounds and preparing solutions.
Preferred solubilizers and media (general):
Use water as primary diluent whenever feasible, with minimal DMSO as cosolvent.
Consider biorenewable or lower-toxicity solvents for preparative work (e.g., 2-MeTHF, CPME, ethyl acetate) in place of chlorinated solvents when compatible with the compound.
Comparison (general characteristics):
Solvent | Greenness highlights | Typical trade-offs
--- | --- | ---
Water | Nonflammable, benign | Limited solubility for hydrophobic compounds
2-MeTHF | Biorenewable, low peroxide tendency vs. THF | Different polarity; may alter reaction/selectivity
CPME | Broad utility, low peroxide formation | Odor, availability, cost
Ethyl acetate | Low toxicity, biodegradable | Limited polarity; not water-miscible
Cyrene (dihydrolevoglucosenone) | Bio-based DMF/DMSO alternative | Viscosity, limited compatibility window
Operational practices:
Minimize solvent volumes, use microscale assays, and adopt high-solids or flow methods where possible.
Implement solvent recovery and waste segregation to enable recycling.
Note: Select solvents only after confirming the compound’s stability and compatibility; these are general recommendations, not item-specific specifications.
Pharmaceutical Uses
No pharmacopeial status, excipient role, or formulation guidance is provided for this item. Given its categorization as a small-molecule library compound, typical usage is confined to discovery research and non-clinical experimentation.
General, non-clinical context only:
Early pre-formulation for in vitro/in vivo research may include assessing solubility in biorelevant media, salt screening for ionizable entities, and simple vehicles (e.g., PEG400/saline, Captisol) after compatibility checks.
Any in vivo use requires institution-specific approvals and thorough safety evaluation; such use is outside the scope of this product listing.
Regulatory note:
Not listed with pharmacopeial monographs in the provided data. No GMP or clinical-grade claims are made. For any regulated application, obtain appropriate grade and documentation.
Conclusion: No pharmaceutical or therapeutic claims are made; this product is for research use only.
Physical Properties
Item-specific physical constants are not provided in the current listing.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
Density: Not specified for this item; refer to CoA/Spec Sheet.
Refractive index (nD): Not specified for this item; refer to CoA/Spec Sheet.
Solubility: Not specified for this item; refer to CoA/Spec Sheet.
logP/logD, pKa: Not specified for this item; refer to CoA/Spec Sheet.
General characterization guidance (literature/general):
For screening compounds, initial solubility is commonly assessed in DMSO (e.g., 10–50 mM stock), then diluted into assay buffers with surfactants (0.01–0.05% Tween-20) if permitted by assay.
Differential scanning fluorimetry (DSF) or nephelometry can help flag aggregation/precipitation on dilution.
If crystalline, DSC/TGA can reveal polymorphs, residual solvents, or hygroscopicity tendencies.
Measure aqueous solubility and pKa via potentiometric or shake-flask methods to inform formulation and assay design.
Note: Do not treat any of the above as specifications for this item; they are general methods. For authoritative, item-specific values consult the CoA/Spec Sheet.
Quality and Grades
Item-specific grade/purity and stabilizers are not provided in the product data and should be confirmed on the CoA/Spec Sheet.
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Stabilizer/Inhibitor: Not specified for this item; refer to CoA/Spec Sheet.
General notes for small-molecule library items:
Typical QC package: HPLC/UPLC purity, 1H NMR, MS/HRMS, and where relevant 13C NMR. Chiral compounds may include enantiomeric excess (ee) by chiral HPLC.
HPLC vs. LC-MS purity: LC-UV purity can overestimate if impurities lack chromophores; LC-MS can detect non-UV-active components. Verify both when critical.
Residual solvents and water: Karl Fischer (KF) and GC headspace data help explain solubility anomalies. If not listed, request on-demand.
Batch-to-batch consistency: Reference the lot-specific CoA for actual purity, residual solvents, and identity confirmation. Do not extrapolate from other lots.
Practical implications:
High-purity materials (>95% by HPLC) are preferred for SAR and HTS triage to reduce false positives.
If UV transparency is required (e.g., for photochemical or chromatography uses), confirm UV cutoff on the CoA; otherwise, treat as unknown.
Reaction and Applications
Manufacturer application notes are not provided for this entry. Given its placement in a small-molecule/compound library, use-cases are generally discovery-oriented rather than as a reagent.
Discovery applications (general):
High-throughput screening (HTS) and fragment/lead identification in biochemical or cell-based assays (research use only).
Secondary assays and orthogonal counterscreens to triage false positives (e.g., aggregation, redox cycling, PAINS behavior).
Early ADME profiling: solubility, permeability (PAMPA/Caco-2), microsomal stability, and plasma protein binding to inform tractability.
If used synthetically (contingent on structure, general):
Without a structure, reaction roles cannot be assigned. Once functional groups are known, assess standard transformations (e.g., coupling, protection/deprotection, oxidation/reduction) as appropriate.
Important: No medical or clinical use is implied. All applications are for research use only, and any item-specific reactivity or assay suitability must be verified from the CoA/SDS and preliminary lab tests.
Reaction Conditions
No reaction conditions are specified for this item. Without a known structure and functional groups, recommended temperatures, catalysts, or solvents cannot be provided.
General literature-based guidance (non-specific):
For cross-couplings (if applicable to structure): Pd-catalyzed Suzuki–Miyaura in 2-MeTHF/water or dioxane/water, bases like K2CO3/Cs2CO3, 40–90 °C; Buchwald–Hartwig amination with dialkylbiaryl phosphines, 60–110 °C.
For amide couplings: HATU/EDC/HOBt alternatives with DIPEA or collidine in DMF, DCM, or greener solvents; 0–25 °C to room temp.
For reductions/oxidations: Choose chemoselective reagents (e.g., NaBH4 vs. DIBAL-H; TEMPO/BAIB vs. Dess–Martin) only after confirming functional groups.
These are general examples from literature and must not be interpreted as specifications for this product. Establish any conditions empirically once the compound’s structure is known.
Safety and Handling
Hazard information is not provided in the current listing. Always consult the product SDS for authoritative guidance.
GHS classification: Not specified for this item; refer to SDS.
Signal word / H-statements / pictograms: Not specified for this item; refer to SDS.
General laboratory safety (applicable to small-molecule solids/liquids):
PPE: Use lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Work in a fume hood to avoid inhalation of dusts/vapors/aerosols.
Avoid contact with skin/eyes. Prevent ingestion and inhalation. Wash hands after handling.
Storage incompatibilities: Until structure is known, store segregated from strong oxidizers and strong acids/bases. Keep container tightly closed, desiccated, and protected from light if photolability is suspected.
Spill response: Contain and collect with inert absorbent (vermiculite, sand). Dispose per institutional and local regulations.
Fire-fighting: Many organics are combustible. Use CO2, dry chemical, or foam as appropriate. Firefighters should wear self-contained breathing apparatus.
Special risks: Some organic compounds may form hazardous dust clouds or decompose upon heating. Avoid aerosolization; use anti-static measures for powders.
First-aid overview (general):
Inhalation: Move to fresh air; seek medical attention if symptoms persist.
Skin/eye contact: Rinse with plenty of water for ≥15 minutes; remove contaminated clothing; seek medical attention if irritation persists.
Ingestion: Rinse mouth; seek medical attention. Do not induce vomiting unless directed by medical personnel.
Solvent Selection
No item-specific solubility profile is provided. The following are general strategies for small-molecule screening compounds.
Stock preparation (general):
Start with DMSO due to broad solubilizing power and assay compatibility; typical screening stocks are 10–50 mM. Filter sterilize if needed (0.22 µm PTFE) and aliquot to minimize freeze–thaw.
If DMSO is unsuitable, evaluate DMF, NMP, ethanol, or aqueous cosolvent systems (e.g., DMSO/H2O with surfactant). Verify assay tolerance for organic content.
Solubility screening workflow:
Small-scale titration with visual inspection/nephelometry.
Sonication and mild warming (<40 °C) can help dissolution if chemically stable.
For ionizable compounds, adjust pH within stability limits (avoid extremes without data).
Dielectric/miscibility (general reference):
DMSO and DMF: high dielectric, miscible with water and many organics; good for polar/ionizable analytes.
Ethyl acetate/MTBE: lower polarity; suitable for nonpolar species but limited aqueous miscibility.
Compatibility cautions:
Avoid reactive solvents (methanol for acyl chlorides; water for moisture-sensitive motifs) once functional groups are known.
Note: These are general practices, not specifications for this item. Confirm chemical compatibility after the structure is obtained.
Storage and Reconstitution
Item-specific storage is provided; reconstitution details are not. Follow the guidance below and consult the CoA/SDS for updates.
Storage conditions (from product data): Store at −20 °C.
Shipping (from product data): Shipped in ice chest with ice pads.
General handling recommendations (not item-specific specifications):
Keep container tightly closed, preferably under inert gas and with desiccant if hygroscopicity is suspected. Protect from light until photostability is known.
Upon receipt, allow the sealed container to equilibrate to room temperature before opening to avoid condensation.
Reconstitution: If solid, prepare a concentrated DMSO stock (e.g., 10–50 mM) if compatible; vortex, sonicate, or gently warm (<40 °C) to assist dissolution. If liquid, verify density to prepare accurate volumetric stocks.
Aliquoting: Dispense single-use aliquots to minimize freeze–thaw cycles; store aliquots at −20 °C. Record preparation dates and concentrations.
Stability: Without item-specific data, assume limited bench stability; return to cold storage promptly and avoid prolonged exposure to moisture/air.
Note: For any lot-specific stability, purity, and solubility information, refer to the CoA/Spec Sheet and SDS. This product is for research use only.
Structure and Identity
Brief overview: This SKU is listed within a small-molecule/compound library category; however, structural identifiers are not provided in the current product data and should be confirmed from the Certificate of Analysis (CoA) or Spec Sheet prior to experimental work.
SKU: B1416505
Product name: BING
CAS: 2396407-35-3
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general guidance):
Functional groups, ring systems, and stereochemistry cannot be described without the structural file. Obtain the compound’s structure (SDF/MOL, SMILES) to assess heteroatoms, aromaticity, and chiral centers.
Confirm identity using one or more orthogonal methods where possible: HRMS (exact mass), 1H/13C NMR, and HPLC/UPLC purity. Compare spectra with supplier data.
If the CAS is newly assigned or uncommon, cross-check in external databases (e.g., CAS Registry, PubChem) using the structure once available.
Synthetic Utility
Item-specific functional groups and reactivity are not provided, so definitive synthetic roles cannot be assigned.
General guidance (contingent on structure):
If the molecule contains common handles (e.g., aryl halides, boronates, carboxylic acids, amines), it may be adapted for diversification via cross-coupling (Suzuki–Miyaura, Buchwald–Hartwig), amide coupling, or SNAr/SN2 transformations.
Protecting group strategies and chemoselectivity depend on functional group compatibility; verify by small-scale scouting experiments.
For chiral centers, consider enantiospecific routes or resolution techniques (diastereomeric salt formation, chiral SFC).
Retrosynthetic considerations:
Map the structure (once obtained) to obvious disconnections: C(sp2)–C(sp2) via boronate/halide pairs, C–N via aryl halide/amine couplings, and C–C via alkylation or radical methods.
Caution: Do not assume reactivity without the structural data. Consult the CoA/structure file and, if needed, conduct micro-scale reactions to establish stability and compatibility.
Target Specificity
Target specificity data (e.g., named protein, pathway, or organism selectivity) are not provided for this item.
Antigen/epitope/clone/isotype: Not applicable; this product is a small molecule, not an antibody or protein reagent.
Any biological target claims should be derived from user-generated data or explicit supplier documentation.
Recommendation: If screening identifies putative targets, validate with orthogonal methods (e.g., CETSA/TPP, chemoproteomics with suitable linkers, genetic knockdown/CRISPR rescue) and establish selectivity against related target families.
자주 묻는 질문
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 2396407-35-3, the molecular formula is C67H125N21O15, and the molecular weight is 1464.84 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.